Prognostic immune markers identifying patients with severe COVID-19 who respond to tocilizumab

Overview of attention for article published in Frontiers in immunology, May 2023

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 2 Dimensions

Readers on

mendeley: 5 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 2 publications that cite this research output.

2

The most recent citing publications are shown below. View all 2 publications that cite this research output on Dimensions.

Immunosenescence and vaccine efficacy revealed by immunometabolic analysis of SARS-CoV-2-specific cells in multiple sclerosis patients

Article in Nature Communications (March 2024)

Metabolic pathways engaged by antigen-specific T and B cells after SARS-CoV-2 vaccination in multiple sclerosis patients on different immunomodulatory drugs reveal immunosenescence and predict vaccine efficacy.

Preprint in Research Square (November 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.